Millennium Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-354,276
Closed -$6.36M 4363
2017
Q4
$6.36M Sell
354,276
-424,795
-55% -$5.23M 0.01% 1620
2017
Q3
$9.19M Sell
779,071
-232,406
-23% -$2.61M 0.01% 1302
2017
Q2
$10.6M Sell
1,011,477
-431,958
-30% -$4.4M 0.02% 1030
2017
Q1
$15.9M Buy
1,443,435
+519,641
+56% +$6.03M 0.03% 779
2016
Q4
$12.5M Buy
923,794
+266,114
+40% +$3.71M 0.03% 798
2016
Q3
$8.1M Buy
657,680
+231,153
+54% +$2.72M 0.01% 1047
2016
Q2
$4.68M Buy
426,527
+251,210
+143% +$2.81M 0.01% 1304
2016
Q1
$1.92M Buy
175,317
+101,319
+137% +$1.28M ﹤0.01% 1800
2015
Q4
$1.28M Sell
73,998
-137,343
-65% -$2.46M ﹤0.01% 2180
2015
Q3
$4.2M Sell
211,341
-280,642
-57% -$6.43M 0.01% 1438
2015
Q2
$8.08M Sell
491,983
-313,011
-39% -$5.43M 0.02% 1107
2015
Q1
$12.5M Sell
804,994
-136,107
-14% -$2.11M 0.02% 900
2014
Q4
$13.4M Buy
941,101
+582,422
+162% +$6.15M 0.03% 813
2014
Q3
$2.33M Buy
358,679
+58,860
+20% +$391K 0.01% 1768
2014
Q2
$2.07M Sell
299,819
-137,549
-31% -$973K 0.01% 1749
2014
Q1
$3.13M Buy
437,368
+328,699
+302% +$2.81M 0.01% 1482
2013
Q4
$1.02M Buy
108,669
+57,024
+110% +$407K ﹤0.01% 2273
2013
Q3
$322K Sell
51,645
-7,581
-13% -$47.4K ﹤0.01% 2821
2013
Q2
$390K Buy
+59,226
New +$470K ﹤0.01% 2459

Other funds holding SCMP

Millennium Management's SCMP Position: Q1 2018 in Review

Millennium Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 354,276 shares — an estimated $6.36M sold.

Millennium Management first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $15.9M in Q1 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Millennium Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Millennium Management sold 354,276 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $6.36M.
  • Millennium Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Millennium Management's Sucampo Pharmaceuticals, Inc. position peaked at $15.9M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.